This live session provides a focused overview of stigma and discrimination affecting individuals with substance use disorders, emphasizing core concepts, real-world impact, and practical strategies for improving patient care.
What This Includes• Definitions and sources of stigma related to substance use disorders• The impact of stigma and discrimination on patient care, treatment access, and outcomes• Stigma across multiple levels, including public attitudes, healthcare systems, and policy environments• Effects of stigma on quality of care and patient engagement• Clinical and real-world examples illustrating the impact of stigma in practice• Strategies to recognize and address stigma through language, behavior, and systems-level change• Approaches to reduce discrimination and improve engagement and outcomes for patients with substance use disorders
What to Expect• Live, faculty-led instruction delivered in an interactive online format• Case-based discussion connecting stigma concepts to real-world clinical scenarios• Structured content aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas• Practical guidance on recognizing stigma and its impact on clinical decision-making• Actionable strategies to improve patient engagement and deliver more equitable, patient-centered care
Miki Kiyokawa, MD
Dr. Kiyokawa is an addiction medicine physician and Associate Professor in the Departments of Medicine and Psychiatry at the University of Hawaiʻi John A. Burns School of Medicine. She serves as Program Director of the Addiction Medicine Fellowship.
To support a meaningful learning experience and recognize your participation: